We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
story of the week

Journal Scan / Research · July 01, 2019

Surgical Safety of Cytoreductive Nephrectomy Following Sunitinib

European Urology


Additional Info

Disclosure statements are available on the authors' profiles:

European Urology
Surgical Safety of Cytoreductive Nephrectomy Following Sunitinib: Results from the Multicentre, Randomised Controlled Trial of Immediate Versus Deferred Nephrectomy (SURTIME)
Eur Urol 2019 Jun 18;[EPub Ahead of Print], RE De Bruijn, P Mulders, MA Jewett, J Wagstaff, JV Van Thienen, CU Blank, R Van Velthoven, L Wood, HE van Melick, MJ Aarts, JB Lattouf, T Powles, IJ De Jong, S Rottey, B Tombal, S Marreaud, S Collette, L Collette, JB Haanen, A Bex

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading